NCT06412042

Probiotic in Infant Growth, Allergy and Immunity Study

Name: Clinical Trial NCT06412042
Creator: Wecare Probiotics Co., Ltd.
Keywords: Healthy,Infant ALL, Probiotic BLa80, dietary supplement, clinical trial, Indonesia

Prospective, Placebo-Controlled, Randomized Double-Blind Clinical Study on the Intervention of Animal-Derived Probiotic in Infant Growth and Development, Allergy Incidence, and Immune Function

Wecare Probiotics Co., Ltd.·ClinicalTrials.gov·dietary supplementNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Healthy,Infant ALL
Drug/Device/Intervention: Probiotic BLa80
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Wecare Probiotics Co., Ltd.
Location: Jakarta Pusat, Indonesia

Timeline & enrollment

Phase: N/A
Start date: Jun 15, 2024
End date: Sep 25, 2024
Enrollment: 40 participants

Primary outcome

Changes in gut microbiota

Summary

To evaluate the intervention effects of Bifidobacterium animalis subsp. lactis strain BLa80 in promoting growth and development (including gut microbiota and physical growth and development) of healthy infants and young children across different age groups, enhancing immune function, improving allergy incidence, and analyzing the safety of BLa80 in relation to infant growth and development, allergy incidence, and gut microbiota.

ICD-10 classifications

Exceptionally large babyHealth supervision and care of other healthy infant and childOther preterm infantsOther feeding problems of newbornFetus and newborn affected by other maternal conditions

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06412042
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06412042 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Not yet recruiting. The study focuses on Healthy,Infant ALL. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.